The store will not work correctly when cookies are disabled.
4-[(tert-butylamino)methyl]-3-carboxy-5-(4-fluorophenyl)-1-phenyl-1H-pyrazole
ID: ALA4764780
PubChem CID: 162661293
Max Phase: Preclinical
Molecular Formula: C21H22FN3O2
Molecular Weight: 367.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)NCc1c(C(=O)O)nn(-c2ccccc2)c1-c1ccc(F)cc1
Standard InChI: InChI=1S/C21H22FN3O2/c1-21(2,3)23-13-17-18(20(26)27)24-25(16-7-5-4-6-8-16)19(17)14-9-11-15(22)12-10-14/h4-12,23H,13H2,1-3H3,(H,26,27)
Standard InChI Key: CUGRIWDQLVRKMX-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
2.4155 -1.3577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6320 -2.1573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2163 -1.5699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1340 -5.8970 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1329 -6.7240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8473 -7.1366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5634 -6.7235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5606 -5.8934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8455 -5.4845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8473 -4.6641 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5139 -4.1783 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2566 -3.3939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4309 -3.3977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1806 -4.1844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4014 -4.4454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7857 -3.8952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0035 -4.1537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8358 -4.9619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4564 -5.5112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2363 -5.2498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7388 -2.7251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5593 -2.8082 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.4007 -1.9729 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.9426 -2.7332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1230 -2.8238 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8151 -2.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0533 -5.2220 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
11 12 2 0
10 11 1 0
12 13 1 0
13 14 2 0
14 10 1 0
9 10 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
14 15 1 0
12 21 1 0
21 22 1 0
21 23 2 0
13 24 1 0
24 25 1 0
25 2 1 0
2 26 1 0
18 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 367.42 | Molecular Weight (Monoisotopic): 367.1696 | AlogP: 4.26 | #Rotatable Bonds: 5 |
Polar Surface Area: 67.15 | Molecular Species: ZWITTERION | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 2.97 | CX Basic pKa: 9.33 | CX LogP: 1.95 | CX LogD: 1.95 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.71 | Np Likeness Score: -1.21 |
References
1. da Silva MJV,Jacomini AP,Figueiredo MC,Back DF,Foglio MA,Ruiz ALTG,Paula FR,Rosa FA. (2021) Efficient synthesis and antitumor evaluation of 4-aminomethyl-N-arylpyrazoles: Discovery of potent and selective agents for ovarian cancer., 29 [PMID:33214037] [10.1016/j.bmc.2020.115835] |